Science
Existing Osteoporosis Drug Blocked Spinal Disc Damage in Zebrafish Study
Picture the rubbery cushions between your vertebrae slowly hardening into bone. That's what happened to zebrafish with a faulty collagen gene, until a drug already prescribed for osteoporosis stepped in and stopped it.
70%share of human genes with a matching zebrafish counterpart
The facts
- 1Zebrafish carrying a faulty collagen-related gene developed spinal disc damage that mimics human disc degeneration, Science Daily reported.
- 2The faulty gene appears to trigger a chain reaction that hardens and deteriorates the spine's natural shock absorbers, the intervertebral discs.
- 3Scientists gave the zebrafish a drug already approved for treating osteoporosis, a bone-thinning disease, and it blocked the spinal damage.
- 4The result suggests an existing, safety-tested medicine could potentially be repurposed to treat disc degeneration, a common cause of chronic back pain.
- 5Zebrafish share a large share of their genes with humans, but the drug's effect must still be confirmed in mammals before any human treatment is possible.
Why it matters
Repurposing an approved drug could shortcut years of safety testing needed for new medicines, offering a faster path toward treating disc degeneration if the effect holds up in mammals and then humans.
Sources
- Science Daily
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
